Together, these observations suggest an essential protective role for ADAMTS2 in the progression of heart failure and cardiac hypertrophy and identify ADAMTS2 and its signaling pathways as potential therapeutic targets. Here, ADAMTS2 is linked to cardiac hypertrophy.